Widely used diabetes drug may offer unexpected health benefit
- Metformin users had a 39% lower one-year risk of death after COVID-19.
- The records study cannot prove metformin caused the difference.
- Researchers say the evidence is not enough to change treatment.
A Stanford study found that adults with type 2 diabetes who were taking metformin before contracting COVID-19 had a 39% lower risk of dying in the following year than those taking a different diabetes drug. The result suggests metformin may have benefits beyond blood sugar control, but it…